Synovus Financial Corp Lowers Position in Danaher Corporation (DHR)

Synovus Financial Corp reduced its stake in shares of Danaher Corporation (NYSE:DHR) by 10.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 83,811 shares of the company’s stock after selling 9,995 shares during the period. Synovus Financial Corp’s holdings in Danaher Corporation were worth $6,590,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. LS Investment Advisors LLC boosted its stake in Danaher Corporation by 1.6% in the second quarter. LS Investment Advisors LLC now owns 193,670 shares of the company’s stock valued at $19,561,000 after buying an additional 3,070 shares during the last quarter. Checchi Capital Advisers LLC raised its position in Danaher Corporation by 2.8% in the second quarter. Checchi Capital Advisers LLC now owns 5,651 shares of the company’s stock valued at $571,000 after buying an additional 155 shares during the period. Macguire Cheswick & Tuttle Investment Counsel LLC raised its position in Danaher Corporation by 3.9% in the second quarter. Macguire Cheswick & Tuttle Investment Counsel LLC now owns 158,760 shares of the company’s stock valued at $16,035,000 after buying an additional 6,000 shares during the period. OLD Second National Bank of Aurora raised its position in Danaher Corporation by 0.6% in the second quarter. OLD Second National Bank of Aurora now owns 13,105 shares of the company’s stock valued at $1,324,000 after buying an additional 79 shares during the period. Finally, Meyer Handelman Co. raised its position in Danaher Corporation by 0.8% in the second quarter. Meyer Handelman Co. now owns 185,550 shares of the company’s stock valued at $18,741,000 after buying an additional 1,500 shares during the period. Institutional investors and hedge funds own 74.73% of the company’s stock.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Shares of Danaher Corporation (NYSE:DHR) traded up 0.11% during trading on Wednesday, hitting $81.19. 1,408,819 shares of the stock were exchanged. The firm’s 50 day moving average price is $78.67 and its 200-day moving average price is $79.06. The stock has a market cap of $56.16 billion, a P/E ratio of 22.71 and a beta of 1.03. Danaher Corporation has a 52 week low of $61.60 and a 52 week high of $82.64.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, October 20th. The company reported $0.87 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.82 by $0.05. The business earned $4.10 billion during the quarter, compared to analysts’ expectations of $4.14 billion. Danaher Corporation had a net margin of 11.78% and a return on equity of 12.90%. The firm’s quarterly revenue was up 17.6% compared to the same quarter last year. During the same period in the prior year, the company earned $1.05 EPS. On average, analysts predict that Danaher Corporation will post $3.57 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 27th. Investors of record on Friday, December 30th will be given a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a yield of 0.62%. The ex-dividend date of this dividend is Wednesday, December 28th. Danaher Corporation’s dividend payout ratio is 13.97%.

TRADEMARK VIOLATION NOTICE: “Synovus Financial Corp Lowers Position in Danaher Corporation (DHR)” was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this news story on another site, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this news story can be read at https://sportsperspectives.com/2017/01/11/synovus-financial-corp-lowers-position-in-danaher-corporation-dhr.html.

Several research analysts recently issued reports on DHR shares. Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $86.00 price target for the company in a research report on Tuesday, September 27th. Evercore ISI reissued a “buy” rating and issued a $89.00 price target on shares of Danaher Corporation in a research report on Wednesday, October 12th. Morgan Stanley reissued an “overweight” rating on shares of Danaher Corporation in a research report on Tuesday, December 13th. RBC Capital Markets set a $86.00 price target on shares of Danaher Corporation and gave the stock a “hold” rating in a research report on Friday, October 21st. Finally, J P Morgan Chase & Co reissued a “buy” rating and issued a $90.00 price target on shares of Danaher Corporation in a research report on Thursday, October 6th. Eight equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company’s stock. Danaher Corporation has a consensus rating of “Buy” and a consensus price target of $92.43.

In related news, insider Thomas Patrick Joyce, Jr. sold 36,125 shares of the company’s stock in a transaction that occurred on Friday, October 21st. The shares were sold at an average price of $79.68, for a total transaction of $2,878,440.00. Following the completion of the transaction, the insider now directly owns 205,407 shares in the company, valued at approximately $16,366,829.76. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 12.60% of the company’s stock.

About Danaher Corporation

Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services.

5 Day Chart for NYSE:DHR

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply